Showing results 3 to 3 of 3
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A) Proceeding/Conference:Journal of Clinical Oncology | 2010 |